Evidence mapPaperPMID 40422942Full record

ReviewJournal of cardiovascular development and disease2025

Non-Traditional Cardiovascular Risk Factors: Tailored Assessment and Clinical Implications.

Francesco Perone, Marco Bernardi, Luigi Spadafora, Matteo Betti, Stefano Cacciatore, Francesco Saia, Federica Fogacci, Vikash Jaiswal, Elad Asher, Francesco Paneni and 4 more

Abstract readReview
In one paragraph

Review in Journal of cardiovascular development and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. SCORE2 Outperforms Pol-SCORE in Detecting Increased Cardiovascular Risk.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Article
  8. Review
  9. Endospore-formingFrontiers in oral health · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Francesco PeroneCardiac Rehabilitation Unit, Rehabilitation Clinic "Villa delle Magnolie", 81020 Castel Morrone, Caserta, Italy.ORCID 0000-0002-1418-7908
Marco BernardiDepartment of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy.
Luigi SpadaforaDepartment of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy.ORCID 0000-0001-6443-4121
Matteo BettiDepartment of Clinical Sciences and Community Health, Cardiovascular Section, University of Milan, 20122 Milan, Italy.ORCID 0009-0008-8458-3747
Stefano CacciatoreDepartment of Geriatrics, Orthopedics and Rheumatology, Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168 Rome, Italy.ORCID 0000-0001-7504-3775
Francesco SaiaInterventional Cardiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola, 40138 Bologna, Italy.ORCID 0000-0001-9969-2649
Federica FogacciHypertension and Cardiovascular Risk Research Center, Medical and Surgical Sciences Department, University of Bologna, 40138 Bologna, Italy.ORCID 0000-0001-7853-0042
Vikash JaiswalDepartment of Cardiovascular Research, Larkin Community Hospital, South Miami, FL 33431, USA.ORCID 0000-0002-2021-1660
Elad AsherJesselson Integrated Heart Center, Shaare Zedek Medical Center Jerusalem and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9103102, Israel.ORCID 0000-0003-3381-605X
Francesco PaneniCenter for Translational and Experimental Cardiology (CTEC), Deapartment of Cardiology, University Hospital Zürich and University of Zürich, Wagistrasse 12, Schlieren, 8952 Zurich, Switzerland.
Salvatore De RosaDepartment of Medical and Surgical Sciences, Magna Graecia University, 88100 Catanzaro, Italy.ORCID 0000-0001-5388-942X
Maciej BanachCiccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, 600 N. Wolfe St., Carnegie 591, Baltimore, MD 21287, USA.ORCID 0000-0001-6690-6874
Giuseppe Biondi ZoccaiDepartment of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100 Latina, Italy.ORCID 0000-0001-6103-8510
Pierre SabouretHeart Institute and Action Group, Pitié-Salpétrière, Sorbonne University, 75013 Paris, France.ORCID 0000-0002-0243-3673

Funding

European Union - NextGenerationEU, through the Italian Ministry of University and Research B53C22004000006
6 · The paper itself

Abstract

Non-traditional cardiovascular risk factors (RFs) are increasingly emerging as important modifiers of cardiovascular risk (CVR), offering insights beyond traditional metrics like hypertension, diabetes, and dyslipidemia. These include novel biomarkers, chronic conditions (e.g., chronic kidney disease and chronic obstructive pulmonary disease), environmental exposures, chronic inflammation, infections, psychosocial factors, and sex-specific conditions, all of which influence the prediction, management, and outcomes of cardiovascular disease (CVD). These additional RFs may impact on CVD prediction and add valid information during tailored patient assessment and management. Therefore, a careful assessment of both traditional and non-traditional cardiovascular RFs, with a personalized treatment, could dramatically reduce the total CVD burden. Nevertheless, further research is needed to precisely estimate the magnitude of their impact as risk and prognosis modifiers in order to be included in future risk charts. This review provides a critical analysis of non-traditional RFs, their pathophysiological mechanisms, and their implications for personalized care. Integrating these factors into CVR assessment can reclassify patient risk categories, optimize therapeutic strategies, and improve prognosis. However, further research is needed to refine their inclusion in risk charts and evaluate their impact on public health outcomes. A tailored, multidisciplinary approach is essential to reduce the burden of CVD and associated mortality.

Indexed as

cardiovascular diseasecardiovascular preventionnon-traditional risk factorsrisk assessmenttraditional risk factors

Identifiers

PMID40422942
PMCPMC12111945

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.